Klacid Kid

Clarithromycin, the active ingredient in Klacid Kid, is a macrolide antibiotic presented as an oral formulation for pediatric use. It is employed to treat a range of bacterial infections in children, including community‑acquired pneumonia, acute bacterial sinusitis, acute otitis media, skin and soft‑tissue infections, and as part of Helicobacter pylori eradication regimens.

GNH USA supplies Klacid Kid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets.

Clarithromycin is a macrolide antibiotic used to treat bacterial infections in the respiratory, ear, skin and gastrointestinal systems. - Community‑acquired pneumonia: reduces bacterial load and improves clinical recovery in pediatric patients. - Acute bacterial sinusitis: eradicates causative organisms, relieving sinus inflammation and congestion. - Acute otitis media: eliminates middle‑ear pathogens, decreasing pain and fever. - Skin and soft‑tissue infections: treats Staphylococcus and Streptococcus species causing cellulitis or impetigo. - Helicobacter pylori eradication (in combination therapy): contributes to bacterial clearance as part of triple‑therapy regimens.

Clarithromycin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild stomach upset or queasiness. - Diarrhea: loose stools, sometimes watery. - Abdominal pain: cramping or discomfort in the stomach area. - Taste disturbance: temporary alteration of taste perception.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or jaundice. - QT prolongation: irregular heart rhythm that may lead to arrhythmia. - Severe allergic reaction: rash, swelling, or anaphylaxis.

When prescribing clarithromycin, clinicians should consider several safety and handling precautions. - Renal impairment: adjust therapy if significant kidney dysfunction is present. - Hepatic disease: monitor liver function tests during treatment. - Concomitant QT‑prolonging drugs: avoid or monitor for cardiac arrhythmias. - Pregnancy and breastfeeding: use only if benefits outweigh potential risks. - Pediatric dosing: ensure appropriate weight‑based dosing as directed by a prescriber. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture.

Clarithromycin interacts with several medicines; awareness of these interactions helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Statins (e.g., simvastatin, lovastatin): risk of rhabdomyolysis; avoid co‑administration. - Carbamazepine and phenytoin: reduced clarithromycin levels; avoid concurrent use. - Ergot derivatives: risk of severe vasospasm; contraindicated.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR; monitor coagulation parameters. - Digoxin: possible increase in serum levels; check concentrations. - Proton pump inhibitors: may affect absorption; observe clinical response.